The worst Ebola virus disease outbreak in history ended in 2016 after infecting 28,600 people and killing about 11,300 worldwide.
The outbreak led to urgent action by medical experts across the world to combat this devastating disease; including the setting up of trials of vaccines to stop the disease taking hold.
This global commitment to develop a vaccine against the disease suggested eight options, out of a starting pool of 15 candidates, should be evaluated in clinical trials worldwide by the end of 2015.
Professor Sanjeev Krishna, of St George’s University of London’s Institute for Infection and Immunity, said: “An unprecedented Ebola outbreak showed how it is possible for academics, non-governmental organisations, industry and funders to work effectively together very quickly in times of medical crisis. The results of the trial show how a vaccine could best be used to tackle this terrible disease effectively.
“We need a system of specialists, medical experts and organisers that maintains vigilance against outbreak diseases like Ebola.
“We should continue to improve ways to make, evaluate and deliver vaccines when they are needed, often in parts of the world lacking in infrastructure for diagnosing infections and providing treatments.”
He explained that considering the persistent replication of the vaccine which is called rVSV-?GP-ZEBOV in children and adolescents, further studies investigating lower doses in this population are warranted.
The vaccine contains a non-infectious portion of a gene from the Zaire Ebola virus. The St George’s researchers worked with colleagues on a vaccine trial in Gabon.
In addition, lower vaccine doses should be considered when boosting individuals with pre-existing antibodies to Ebolavirus glycoprotein, a finding that has emerged after the vaccine was tested in a country that has experienced Ebolavirus outbreaks in the past.
The vaccine was one of two being examined as a ‘candidate’ option by the World Health Organisation to identify urgently a vaccine to combat the Ebola virus outbreak in West Africa.
The clinical trial was led by colleagues at University of Tübingen in Germany, coordinated by Professor Peter Kremsner with their partner institute CERMEL in Lambaréné, Gabon.
The Latest on: Ebola vaccine
- Merck: FDA Grants Priority Review For Investigational Ebola Vaccineon September 17, 2019 at 4:18 am
(RTTNews) - Merck (MRK) reported that the FDA has granted priority review for the company's Biologics License Application for V920, an investigational Ebola vaccine. The PDUFA, or target action ...
- FDA accepts Merck application for Ebola vaccineon September 17, 2019 at 4:08 am
The FDA accepts under Priority Review Merck's (NYSE:MRK) marketing application for its Ebola vaccine (V920). The agency's action date is March 14, 2020.
- Merck's V920 Ebola treatment granted priority review by the FDAon September 17, 2019 at 3:55 am
Merck & Co. Inc. MRK, -0.70% said Tuesday the Food and Drug Administration has accepted the biologics license application (BLA) for its V920 investigational vaccine for Ebola Zaire virus. The ...
- Explosion Hits Russian Virus Research Center That Houses Smallpox and Ebolaon September 17, 2019 at 2:55 am
Spread across dozens of acres, it employs thousands of workers. It is considered to be one of the world's leading epidemiological research centers, developing an Ebola vaccine earlier this year, ...
- Russia explosion: Blast at mysterious facility housing Ebola, anthrax and smallpoxon September 17, 2019 at 12:41 am
It is also credited with developing an ebola vaccine this year. Nikolai Krasnikov, head of the administration at Vector, told TASS in February: “Our scientists have wrapped up clinical trials of the ...
- Uhh, Part of the Facility Where Russia Stores Smallpox and Ebola Explodedon September 16, 2019 at 8:27 pm
As the Bulletin of Atomic Scientists noted, Vector is considered one of the world’s leading epidemiological research centers (credited with developing an Ebola vaccine this year), but it and the ...
- As Congo’s Ebola Outbreak Drags On, Untracked Cases Sow Confusionon September 16, 2019 at 4:12 pm
Health care workers, some of whom were not vaccinated, continue to die of Ebola. That’s mystifying, since more than 200,000 doses of vaccine have been given out. The W.H.O. said it had received only ...
- Congo arrests former health minister for alleged misuse of Ebola fundson September 16, 2019 at 2:16 pm
NIAID has helped pay for the purchase and distribution of an experimental Ebola vaccine, which now has been given to 220,000 people in the DRC. Officials contend the vaccine has helped slow the spread ...
- Aberdeen doctor on the war front claims thousands of lives saved by new Ebola vaccineon September 11, 2019 at 12:15 am
An Aberdeen-raised doctor claims already nearly 10,000 lives have been saved by a new vaccine for one of the world’s deadliest diseases. Catherine Houlihan returned to the UK in June after a four-week ...
- British doctor who helped fight Ebola praises an experimental vaccineon September 10, 2019 at 8:13 am
A British doctor who has helped fight Ebola in the Democratic Republic of Congo says an experimental vaccine 'has changed the path of the outbreak'. Dr Catherine Houlihan, from Aberdeen, returned home ...
via Google News and Bing News